Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo

Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo

Recent advances in RNA interference (RNAi)-based drug development have partially allowed systemic administration of these agents in vivo with promising therapeutic effects. However, before chemically modified small-interfering RNAs (siRNAs) can be applied clinically, their in vivo effects should be...

Full description

Saved in:
Bibliographic Details
Main Authors: Shunsuke Wada (Author), Satoshi Obika (Author), Masa-Aki Shibata (Author), Tsuyoshi Yamamoto (Author), Moeka Nakatani (Author), Tetsuji Yamaoka (Author), Hidetaka Torigoe (Author), Mariko Harada-Shiba (Author)
Format: Book
Published: Elsevier, 2012-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items